DAPTA

Discontinued Product

2423 has been discontinued.

View all Chemokine CC Receptors products.
说明: Chemokine receptor 5 (CCR5) antagonist
别名: D-Ala-peptide T-amide
说明书
引用文献
评论
文献 (1)

生物活性 for DAPTA

DAPTA is a chemokine receptor 5 (CCR5) antagonist. Acts as a selective viral entry inhibitor for R5 tropic HIV-1 strains. Blocks CCR5-mediated monocyte chemotaxis and reduces microglia and astrocyte activation in a neuroinflammatory rat model of Alzheimer's disease.

技术数据 for DAPTA

分子量 856.89
公式 C35H56N10O15
序列 ASTTTNYT

(Modifications: Ala-1 = D-Ala, Thr-8 = C-terminal amide)

储存 Desiccate at -20°C
CAS Number 106362-34-9
PubChem ID 184644
InChI Key AKWRNBWMGFUAMF-ZESMOPTKSA-N
Smiles [H]N[C@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(N)=O

上方提供的技术数据仅供参考。批次相关数据请参见分析证书。

Tocris products are intended for laboratory research use only, unless stated otherwise.

产品说明书 for DAPTA

分析证书/产品说明书
选择另一批次:

按产品操作查看相关产品

查看全部 Chemokine CC Receptor Antagonists

关键词: DAPTA, DAPTA supplier, Chemokine, receptor, 5, CCR5, antagonists, CXCR, Receptors, antiviral, Rantes, D-Ala-peptide, T-amide, CC, HIV, 2423, Tocris Bioscience

篇 DAPTA 的引用文献

引用文献是使用了 Tocris 产品的出版物。

目前没有 DAPTA 的引用文献。

DAPTA 的评论

目前没有该产品的评论。 Be the first to review DAPTA and earn rewards!

Have you used DAPTA?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

该领域的文献

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*请注意,Tocris 仅会向正规科研企业/机构地址发送文献。


Rheumatoid Arthritis Poster

Rheumatoid Arthritis Poster

Rheumatoid arthritis (RA) is a chronic destructive inflammatory autoimmune disease that results from a breakdown in immune tolerance, for reasons that are as yet unknown. This poster summarizes the pathology of RA and the inflammatory processes involved, as well as describing some of the epigenetic modifications associated with the disease and the potential for targeting these changes in the discovery of new treatments.